Procurement Summary
Country: Ukraine
Summary: Potassium Asparaginate/Magnesium Asparaginate Solution for Injections of 10 Ml; Epinephrine 1.82 Mg/Ml, Solution for Injection, Ampoule; Amiodarone, Solution for Injection, 50 Mg/Ml, 3 Ml Each; Chloropyramine, Solution for Injection...
Deadline: 17 Jul 2026
Posting Date: 17 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 145345335
Document Ref. No.: UA-2026-07-14-000937-a
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: UAH 120293.98
CPV Classification
33600000 - Pharmaceutical products
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33670000 - Medicinal products for the respiratory system
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Potassium asparaginate/Magnesium asparaginate solution for injections of 10 ml; Epinephrine 1.82 mg/ml, solution for injection, ampoule; Amiodarone, solution for injection, 50 mg/ml, 3 ml each; Chloropyramine, solution for injection, 20 mg/ml, 1 ml each; Amiodarone, tablets, 200 mg each; Bisoprolol tablets of 5 mg; Bupivacaine, solution for injection, 5 mg/ml, 10 ml each; Povidone-iodine, solution for external use, 10%, 100 ml each; Dexamethasone, solution for injection 4mg/ml; Diphenhydramine, solution for injection, 10 mg/ml, 1 ml each; Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule; Enalapril 10 mg tablets; Ondansetron solution for injection 2 mg/ml in 2 ml; Iodine, solution for external use, 5%, 20 ml each; Nifedipine 10 mg tablets; Diosmin (combinations), tablets, 1000 mg each; Hydrogen peroxide, solution, 3%, 100 ml each; Pancreatin, Lipolytic units: 8000; Inosine, solution for injection, 20 mg/ml, 10 ml each; Meloxicam 15 mg tablets; Ethyl alcohol 70% 100 ml.; Ethyl alcohol 96% 100 ml.; Ibuprofen tablets/capsules of 400 mg; Piracetam, solution for injections, 200 mg/ml, 10 ml each; Thiotriazoline, solution for injection, 25 mg/ml, 4 ml each; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Fluconazole, tablets/capsules, 50 mg each; Human insulin (Combination: 30% Short-acting; 70% Medium duration of action), suspension for injection, 100 U/ml, bottle, 10 ml each; Human insulin (short-acting), solution for injection, 100 U/ml, bottle, 10 ml; Chlorhexidine, solution for external use 0.05% ... Purchase type: goods Classifier and its corresponding code: DC 021:2015: 33600000-6 — Pharmaceutical products Classification according to ATX: D08AC02, INN: Chlorhexidine, Release form: Solution for external use, Dose of active substance: 0.05%, Volume: 100 ml, Packaging type: Vial; Lipoeva acid solution for infusions, 30 mg/ml in 20 ml Thioctic acid, A16AX01, Solution for infusions, 30 mg/ml, 20, Ampoule, Vial; Citicoline: Classification according...
Documents
Tender Notice